Lithuania Travel Vaccine Market to 2032
Overview
The Lithuania Travel Vaccine Market is expected to reach a 32.86 USD Million by 2032 and is projected to grow at a CAGR of 8.86% from 2025 to 2032.
Revenue, 2024 (USD Million)
19.19
Forecast, 2032 (USD Million)
32.86
CAGR, 2024 - 2032
8.86%
Report Coverage
Lithuania
Lithuania Travel Vaccine Market 2018-2032 USD Million
Lithuania Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 19.19 USD Million
- Projected Market Size (2032): 32.86 USD Million
- CAGR (2025-2032): 8.86%
Key Findings of Lithuania Travel Vaccine Market
- The Lithuania Travel Vaccine Market was valued at 32.86 USD Million in 2024.
- The Lithuania Travel Vaccine Market is likely to grow at a CAGR of 8.86% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 15.77 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 17.36% during the forecast period from 2024 to 2032.
Lithuania Travel Vaccine Market Scope
Lithuania Travel Vaccine Market Segmentation & Scope
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Distribution Channel
- B2C
- B2B
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Lithuania Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 19.19 USD Million |
| Market Value in 2032 | 32.86 USD Million |
| CAGR (2025-2032) | 8.86% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Age Group,Patient Type,Gender,Route of Administration,Disease,Distribution Channel,Category,Type,Composition |
Regional Insights:
-
Leading Market (2024-2032): Lithuania, leading in terms of revenue 19.19 USD Million in 2024
- Key Country: Lithuania, leading in terms of revenue with value of 19.19 USD Million in 2024.
Segments and Scope
-
Lithuania Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 9.75 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.30 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 8.91 USD Million in the year 2024.
- Adult is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.48 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 10.27 USD Million in the year 2024.
- Male is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.07 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 15.77 USD Million in the year 2024.
- Injectable is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.00 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 2.94 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 17.36 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 14.94 USD Million in the year 2024.
- B2B is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.02 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 9.18 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.26 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 5.72 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.90 % in forecast period 2025-2032.
-
Lithuania Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in Lithuania Travel Vaccine Market to 2032 with a revenue of 13.31 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in Lithuania Travel Vaccine Market to 2032 with a Growth rate of 9.01 % in forecast period 2025-2032.
Lithuania Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
Lithuania Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
Lithuania Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Lithuania Travel Vaccine Market is segmented based on Segmentation Age Group,Patient Type,Gender,Route of Administration,Disease,Distribution Channel,Category,Type,Composition.
Lithuania Travel Vaccine Market was valued at USD 19.19(Revenue in USD Million) in 2022.
Lithuania Travel Vaccine Market is projected to grow at a CAGR of 8.86% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Lithuania Travel Vaccine Market, holding a largest market share of 15.77 USD Million in 2024
Lithuania Travel Vaccine Market Scope
Lithuania Travel Vaccine Market Segmentation & Scope
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Distribution Channel
- B2C
- B2B
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Frequently Asked Questions
The Lithuania Travel Vaccine Market is segmented based on Segmentation Age Group,Patient Type,Gender,Route of Administration,Disease,Distribution Channel,Category,Type,Composition.
Lithuania Travel Vaccine Market was valued at USD 19.19(Revenue in USD Million) in 2022.
Lithuania Travel Vaccine Market is projected to grow at a CAGR of 8.86% during the forecast period of 2024 to 2032.
The estimated market value of the Lithuania Travel Vaccine Market for final year is USD 32.86 (USD Million).
Lithuania Travel Vaccine Market Company Profiling
Frequently Asked Questions
The Lithuania Travel Vaccine Market is segmented based on Segmentation Age Group,Patient Type,Gender,Route of Administration,Disease,Distribution Channel,Category,Type,Composition.
Lithuania Travel Vaccine Market was valued at USD 19.19(Revenue in USD Million) in 2022.
Lithuania Travel Vaccine Market is projected to grow at a CAGR of 8.86% during the forecast period of 2024 to 2032.
The estimated market value of the Lithuania Travel Vaccine Market for final year is USD 32.86 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.